[2P-0850] Isolation and analysis of cancer cell fraction with high self-renewal activity in patient-derived gastric cancer

〇Risa Iwasaki^1,2, Tetsuo Mashima¹, Naomi Kawata^1,3, Koshi Kumagai⁴, Takeshi Sano⁴, Kensei Yamaguchi³, Hiroyuki Seimiya^1,2 (1.Div. Mol. Biother., Cancer Chemother. Ctr., JFCR, 2.Dept. Med. Sci., Grad. Sch. Frotier Sci., Univ. Tokyo, 3.Dept. Gastroent Med., Cancer Inst. Hosp., JFCR, 4.Dept. Gastroent Surg., Cancer Inst. Hosp., JFCR)

ConBio2017

[2P-0851] Evaluation of four serum microRNAs as candidates for early-stage lung cancer marker: A comparison of the concentrations in sera between before and after surgery

〇Toshiko Aiso¹, Makiko Ueda¹, Kouki Ohtsuka², Shin Karita³, Takuma Yokoyama⁴, Naoko Matsuki⁵, Hiroaki Ohnishi² (1.Dept. of Med. Tech., Fac. of Health Sci., Univ. of Kyorin , 2.Dept. of Lab. Med., Sch. of Med., Univ. of Kyorin, 3.Dept. of Gen. Thoracic Surg. Sch. of Med., Univ. of Kyorin, 4.Dept. of Respiratory Med., Sch. of Med., Univ. of Kyorin, 5.Dept. of Ophthalmol., Sch. of Med., Univ. of Kyorin)

ConBio2017

[2P-0852] Functional analysis of HIF activating factor Mint3 in tumor-associated macrophages.

〇Tetsuro Hayashi¹, Yuya Fukui¹, Takeharu Sakamoto¹, Yoshinori Murakami¹ (1.Div. of Mol. Pathol., Inst. of Med. Sci., Univ. of Tokyo)

ConBio2017

[2P-0853] Analysis of transcriptomic features associated with sensitivity to microtubule inhibitor in non-small cell lung cancer

〇Hitomi Okazaki^1,2, Ayako Suzuki¹, Katsuya Tsuchihara^1,2 (1.Div. Translational Genomics, EPOC, Natl. Cancer Ctr., 2.Dept. of Integ. Biosci., Grad. Sch. of Front. Sci., Univ. of Tokyo)

ConBio2017

[2P-0854] Synergism of SASP factors:activation mechanism of interleukin-33 (IL-33) in senescent hepatic stellate cells (HSCs) in promoting obesity-associated liver cancer

〇Shota Yamazaki¹, Humitaka Kamachi¹, Masaru Nakamura¹, Masahiro Nakajima¹, Loo T Mun², Shin Yoshimoto², Tatsuya Arai¹, Hayao Taguchi¹, Susumu Nakae³, Eiji Hara⁴, Naoko Ohani⁵ (1.Dept. of Bio. Sci., Grad. Sch. of Sci Tech., Univ. of Tokyo, 2.Div. of Canc Bio., Canc Insti., Japan, 3.Lab. of Sys Bio., Exp Med and Sys Bio., Univ. of Tokyo, 4.Dep. of Med., Univ. of Osaka, 5.Dep. of Med., Univ . of Osaka city)

ConBio2017

[2P-0855] Development of the combination therapy targeting ALK and p53 for neuroblastomas

〇Makoto Miyazaki¹, Yuko Hibiya¹, Hidenobu Suzuki^1,2, Ayana Nakajima^1,3, Naomi Abe¹, Koichi Ichimura¹, Arata Tomiyama^1,4 (1.Div. Brain Tumor Translational Res., Natl. Cancer Ctr. Res. Inst., 2.NCC Cancer Sci., Tokyo Med. & Dent. Univ., 3.Grad. Sch. of Med. Life Sci. Yokohama City Univ., 4.Dept. Neurosurg. Natl. Def. Med. Col.)

ConBio2017

[2P-0856] Mechanistic analysis of FABP5 gene expression in colorectal cancer cells

〇Tsubasa Ohashi¹, Koichiro Kawaguchi³, Chisa Yumoto², Hiroshi Fujii^1,2,3 (1.Grad. School of Science and Technology, Univ. of Shinshu, 2.Dept. Biosci. & Biotechnol., Univ. of Shinshu, 3.Interdisciplinary Grad. Sch. Sci. & Technol., Univ. of Shinshu)

ConBio2017

[2P-0857] Effect of the interaction between cell adhesion molecules and extracellular matrix and the elastic modulus in cancer metastasis

〇Hirotomo Shibaguchi¹, Naoto Shirasu¹, Shin'ichiro Yasunaga¹ (1.Dept. of Biochem., Faculty Med., Fukuoka Univ.)

ConBio2017

[2P-0858] Small molecule inhibitor of fibroblast migration enhanced by cancer cells

〇Nobumoto Watanabe^1,2, Kruthi Suvarna^1,2, Kaori Honda¹, Yasumitsu Kondoh³, Hiroyuki Osada³ (1.Bio-Active Comp. Disc. Res. U., RIKEN CSRS, 2.Riken Mol. Chem. Somatol., Grad. Sch. Med. Dent. Sci. TMDU, 3.Chem. Biol. Res. G. RIKEN CSRS)

ConBio2017

[2P-0859] Evolution of drug resistance in three-dimensional suspended culture platform

〇Risa Ito¹, Toshihiro Suzuki¹, Toshimitsu Yamaoka², Tohru Ohmori², Kazuto Nishio³, Yuki Ogasawara¹ (1.Dept. of Analytical Biochem., Meiji Pharm Univ., Japan, 2.Inst. of Mol. Oncol., Showa Univ., Sch. of Med., Japan, 3.Dept. of Genome Biol., Kinki Univ., Sch. of Med., japan)

ConBio2017